272 related articles for article (PubMed ID: 26216987)
1. Role of ubiquitin and the HPV E6 oncoprotein in E6AP-mediated ubiquitination.
Mortensen F; Schneider D; Barbic T; Sladewska-Marquardt A; Kühnle S; Marx A; Scheffner M
Proc Natl Acad Sci U S A; 2015 Aug; 112(32):9872-7. PubMed ID: 26216987
[TBL] [Abstract][Full Text] [Related]
2. The active form of E6-associated protein (E6AP)/UBE3A ubiquitin ligase is an oligomer.
Ronchi VP; Klein JM; Edwards DJ; Haas AL
J Biol Chem; 2014 Jan; 289(2):1033-48. PubMed ID: 24273172
[TBL] [Abstract][Full Text] [Related]
3. A ubiquitin variant-based affinity approach selectively identifies substrates of the ubiquitin ligase E6AP in complex with HPV-11 E6 or HPV-16 E6.
Ebner FA; Sailer C; Eichbichler D; Jansen J; Sladewska-Marquardt A; Stengel F; Scheffner M
J Biol Chem; 2020 Oct; 295(44):15070-15082. PubMed ID: 32855237
[TBL] [Abstract][Full Text] [Related]
4. Multiple regions of E6AP (UBE3A) contribute to interaction with papillomavirus E6 proteins and the activation of ubiquitin ligase activity.
Drews CM; Brimer N; Vande Pol SB
PLoS Pathog; 2020 Jan; 16(1):e1008295. PubMed ID: 31971989
[TBL] [Abstract][Full Text] [Related]
5. Involvement of a cellular ubiquitin-protein ligase E6AP in the ubiquitin-mediated degradation of extensive substrates of high-risk human papillomavirus E6.
Matsumoto Y; Nakagawa S; Yano T; Takizawa S; Nagasaka K; Nakagawa K; Minaguchi T; Wada O; Ooishi H; Matsumoto K; Yasugi T; Kanda T; Huibregtse JM; Taketani Y
J Med Virol; 2006 Apr; 78(4):501-7. PubMed ID: 16482544
[TBL] [Abstract][Full Text] [Related]
6. An Angelman syndrome substitution in the HECT E3 ubiquitin ligase C-terminal Lobe of E6AP affects protein stability and activity.
Beasley SA; Kellum CE; Orlomoski RJ; Idrizi F; Spratt DE
PLoS One; 2020; 15(7):e0235925. PubMed ID: 32639967
[TBL] [Abstract][Full Text] [Related]
7. Stepwise multipolyubiquitination of p53 by the E6AP-E6 ubiquitin ligase complex.
Masuda Y; Saeki Y; Arai N; Kawai H; Kukimoto I; Tanaka K; Masutani C
J Biol Chem; 2019 Oct; 294(41):14860-14875. PubMed ID: 31492752
[TBL] [Abstract][Full Text] [Related]
8.
Ronchi VP; Kim ED; Summa CM; Klein JM; Haas AL
J Biol Chem; 2017 Nov; 292(44):18006-18023. PubMed ID: 28924046
[TBL] [Abstract][Full Text] [Related]
9. Structural dynamics of the E6AP/UBE3A-E6-p53 enzyme-substrate complex.
Sailer C; Offensperger F; Julier A; Kammer KM; Walker-Gray R; Gold MG; Scheffner M; Stengel F
Nat Commun; 2018 Oct; 9(1):4441. PubMed ID: 30361475
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus E6-induced degradation of E6TP1 is mediated by E6AP ubiquitin ligase.
Gao Q; Kumar A; Singh L; Huibregtse JM; Beaudenon S; Srinivasan S; Wazer DE; Band H; Band V
Cancer Res; 2002 Jun; 62(11):3315-21. PubMed ID: 12036950
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus type 16 E6 induces self-ubiquitination of the E6AP ubiquitin-protein ligase.
Kao WH; Beaudenon SL; Talis AL; Huibregtse JM; Howley PM
J Virol; 2000 Jul; 74(14):6408-17. PubMed ID: 10864652
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitination of the HPV Oncoprotein E6 Is Critical for E6/E6AP-Mediated p53 Degradation.
Li S; Hong X; Wei Z; Xie M; Li W; Liu G; Guo H; Yang J; Wei W; Zhang S
Front Microbiol; 2019; 10():2483. PubMed ID: 31749782
[TBL] [Abstract][Full Text] [Related]
13. c-Abl phosphorylates E6AP and regulates its E3 ubiquitin ligase activity.
Chan AL; Grossman T; Zuckerman V; Campigli Di Giammartino D; Moshel O; Scheffner M; Monahan B; Pilling P; Jiang YH; Haupt S; Schueler-Furman O; Haupt Y
Biochemistry; 2013 May; 52(18):3119-29. PubMed ID: 23581475
[TBL] [Abstract][Full Text] [Related]
14. The HECT E3 Ligase E6AP/UBE3A as a Therapeutic Target in Cancer and Neurological Disorders.
Owais A; Mishra RK; Kiyokawa H
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32751183
[TBL] [Abstract][Full Text] [Related]
15. Identification of E6AP-independent degradation targets of HPV E6.
Vats A; Thatte J; Banks L
J Gen Virol; 2019 Dec; 100(12):1674-1679. PubMed ID: 31609195
[TBL] [Abstract][Full Text] [Related]
16. Kinetic analysis of the interactions of human papillomavirus E6 oncoproteins with the ubiquitin ligase E6AP using surface plasmon resonance.
Zanier K; Charbonnier S; Baltzinger M; Nominé Y; Altschuh D; Travé G
J Mol Biol; 2005 Jun; 349(2):401-12. PubMed ID: 15890204
[TBL] [Abstract][Full Text] [Related]
17. The stability of the human papillomavirus E6 oncoprotein is E6AP dependent.
Tomaić V; Pim D; Banks L
Virology; 2009 Oct; 393(1):7-10. PubMed ID: 19700180
[TBL] [Abstract][Full Text] [Related]
18. Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53.
Martinez-Zapien D; Ruiz FX; Poirson J; Mitschler A; Ramirez J; Forster A; Cousido-Siah A; Masson M; Vande Pol S; Podjarny A; Travé G; Zanier K
Nature; 2016 Jan; 529(7587):541-5. PubMed ID: 26789255
[TBL] [Abstract][Full Text] [Related]
19. The role of E6AP in the regulation of p53 protein levels in human papillomavirus (HPV)-positive and HPV-negative cells.
Talis AL; Huibregtse JM; Howley PM
J Biol Chem; 1998 Mar; 273(11):6439-45. PubMed ID: 9497376
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of the transfer of ubiquitin from UbcH7 to E6AP.
Purbeck C; Eletr ZM; Kuhlman B
Biochemistry; 2010 Feb; 49(7):1361-3. PubMed ID: 20039703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
